Biocompare visited USCN

Cloud-Clone Corp.
David Tong, the Asia Pacific Manager of Biocompare visited USCN on June 18th,2012.
 
Biocomapre was established since 1999, currently employing over 100 people. It is an  international and influential media platform for professional internet practice of the field of biology. In case of strongly recommendation from our Korea customers two years ago and our long time inspection and evaluation, the two sides established cooperative relationship since 2011.
 
Firstly, David Tong visited the various departments of our company, he observed the completed automated production lines at production department and understood the scale and progress of the various R&D projects from R&D center. Subsequently, the CEO of USCN, Li Huayuan, the general manager, Dr. He Fengrong, David Tong and related persons in charge of network held a harmonious conversation. Our network responsible person put forward friendly advise on Biocompare's currently problems in China. David Tong said the proposal would play a very important role in development in the Asia Pacific region. David Tong also said he had been to many well-kwon biological reagents company. Through the field visit, it is easy to judge the strength of USCN. They are greatly willing to objectively show our company and brand strength to their user groups since he learned about our company.